Searchable abstracts of presentations at key conferences in endocrinology

ea0011p195 | Clinical practise and governance | ECE2006

Long-term outcome in men with microprolactinoma

Rea R , Jeffcoate W

Introduction: It is accepted that hyperprolactinaemia associated with microprolactinoma may prove self-limiting in 25–30% women, and there is some suggestion from series of mixed gender that the same may be true in men.Methods: We have therefore reviewed the outcome in all men with microprolactinomas managed at the Department of Diabetes and Endocrinology, City Hospital, Nottingham, between 1994 and 2002. All had sustained and previously untreated h...

ea0019p34 | Clinical practice/governance and case reports | SFEBES2009

Primary hyperparathyroidism: dual localisation to improve cure rate

Wilmot E , Cozens N , Birchall J , Lingam K , Rea R

Aims: Primary hyperparathyroidism is a common endocrine disorder. A preoperative approach that combines ultra-sonography and scintigraphy has been shown to predict the presence of adenomas more accurately than either technique alone. We aimed to investigate our local success rates using dual localisation for parathyroid adenomas.Methods: Endocrine patients who had a parathyroidectomy between July 2006 and January 2008 were identified. Hospital notes were...

ea0019p368 | Thyroid | SFEBES2009

Efficacy and complications of radioiodine therapy in benign thyroid disease

Seetho I , Ibbett D , Birchall J , Rea R

The RCP clinical guideline on Radioiodine in the management of benign thyroid disease was published in 2007. An audit was undertaken in patients receiving this treatment between April 2006 and April 2007. The audit was performed to assess compliance with the guidelines and provide patients receiving radioiodine data regarding the efficacy of the treatment and its complications.Sixty-two patients received radioiodine and 59 patients entered into the audit...

ea0011p194 | Clinical practise and governance | ECE2006

Patients with serum prolactin >20,000 mU/l – review of presentation, management and outcome

Seevaratnam N , Khoo E , Rea R , Mansell P

Introduction: Large prolactinomas are uncommon and there is limited information on their presentation and progression. In this study we reviewed the presenting features, associated endocrinopathy and the response to treatment.Methods: 16 patients (aged 20–80 years, 75% male) were identified from our endocrine database as presenting with prolactin >20,000 mU/l between 1985 and 2005.Results: 75% of patients presented with ma...